Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Cell and Gene Therapy
1:12
Optimism for NK cell therapy as a future Alzheimer’s disease treatment
Paul Y Song
• 18 Jul 2023
1:24
Natural killer cell integrity within Alzheimer’s disease
Paul Y Song
• 18 Jul 2023
1:13
Current research into NK cell therapy and the potential for use in other conditions
Paul Y Song
• 18 Jul 2023
2:40
Phase I trial of NK cell therapy in advanced Alzheimer’s disease
Paul Y Song
• 18 Jul 2023
7:55
All-in-one AAV vector for epigenome editing shows efficient APOE downregulation in vivo
Boris Kantor
• 15 Mar 2023
7:12
Benefits of an all-in-one AAV CRISPR/Cas9 system for genome/epigenome editing
Boris Kantor
• 15 Mar 2023
4:55
Novel genome editing approaches under investigation in Alzheimer’s disease
Boris Kantor
• 15 Mar 2023
3:27
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD
Matthew Keuss
• 17 Mar 2023
5:00
Viral-mediated gene therapy for neurodegenerative disease
Boris Kantor
• 29 Jul 2022
3:39
Improving the precision and safety of CRISPR/Cas genome editing
Boris Kantor
• 29 Jul 2022
5:02
Developing APOE-targeted epigenome therapy for the treatment of Alzheimer’s disease
Boris Kantor
• 29 Jul 2022